WebsiteGear Logo Log In
New User? Sign Up
About | Contact | FAQ
  Home News Website Related Online Marketing Friday, June 22, 2018 
Add Press Release News | News Feeds Feeds | Email This News Email


Global CNS Therapeutics Market 2018-2022: Increased Adoption of New-Generation Drugs
Thursday, June 14, 2018

DUBLIN, June 14, 2018 /PRNewswire/ --

The "Global CNS Therapeutics Market 2018-2022" report has been added to ResearchAndMarkets.com's offering.

http://mma.prnewswire.com/media/539438/Research_and_Markets_Logo.jpg

The Global CNS therapeutics market to grow at a CAGR of 4.36% during the period 2018-2022.

Global CNS Therapeutics Market 2018-2022, has been prepared based on an in-depth market analysis with inputs from industry experts. CNS therapeutics cater to CNS disorders that affect the structure or function of the brain or spinal cord such as Parkinson's disease, epilepsy, Alzheimer's disease, anxiety, depression, and bipolar disorders. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market. To calculate the market size, the report considers the revenue generated from the sales of therapeutics for CNS disorders.

The increased adoption of new-generation drugs will be a key trend for the market growth. First-generation and second-generation drugs have many side-effects, limited therapeutic range, and complicated pharmacokinetics. Third-generation drugs have longer therapeutic ranges and limited side effects in comparison to the second-generation drugs, driving the adoption of third-generation drugs.

According to the report, the increasing prevalence of mental illness will drive the market growth. Mental disorders coexist with diseases such as diabetes, cardiovascular disease, or obesity. The increased disease burden and mental disorders requires the availability of effective therapeutics for mental health to decrease the number of deaths caused due to mental illness.

Further, the report states that the side effects of CNS therapeutics will impact the market growth. Therapeutics for CNS disorders have numerous risks and side-effects such as drowsiness and weight gain, insomnia, lowered libido, tremors, and agitation. Also, anti-epilepsy medications result in periodic mood swings that are consequent in depression and anxiety.

Market Trends

    --  Increasing awareness programs
    --  Increased adoption of new-generation drugs

    --  Advances in technology in treating mental disorders

Key vendors

    --  Eli Lilly
    --  F. Hoffmann-La Roche
    --  Johnson & Johnson
    --  Merck
    --  Novartis

Key Topics Covered:

Part 01: Executive Summary

Part 02: Scope Of The Report

Part 03: Research Methodology

Part 04: Market Landscape

Part 05: Market Sizing

Part 06: Five Forces Analysis

Part 07: Customer Landscape

Part 08: Market Segmentation By End-User

Part 09: Regional Landscape

Part 10: Decision Framework

Part 11: Drivers And Challenges

Part 12: Market Trends

Part 13: Vendor Landscape

Part 14: Vendor Analysis

Part 15: Appendix

For more information about this report visit https://www.researchandmarkets.com/research/dxkghf/global_cns?w=5

Media Contact:

Laura Wood, Senior Manager
press@researchandmarkets.com

For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716

View original content:http://www.prnewswire.com/news-releases/global-cns-therapeutics-market-2018-2022-increased-adoption-of-new-generation-drugs-300665741.html

SOURCE Research and Markets



Email This News Email | Submit To Slashdot Slashdot | Submit To Digg.com Digg | Submit To del.icio.us Del.icio.us | News Feeds Feeds

RELATED NEWS ARTICLES
Nav Xulon Press Announces the Release of "What Kind of People" | Jun 22, 2018
Nav Xulon Press Announces the Release of The Power of Relationship | Jun 22, 2018
Nav Elliott Law Group, Leading Immigration Attorneys Servicing Spokane, Washington, and Coeur d'Alene, Idaho, Announces Statement on Immigration Crisis at US / Mexican Border | Jun 22, 2018
Nav Rachael Chesley and Shannon Lane Join Purchasing Power® as Regional Sales Directors, Southwest & Northeast Territories | Jun 21, 2018
Nav Global Loudspeakers Strategic Market, 2016-2024: Connectivity Emerges Into the Most Vital Feature for Modern Speakers | Jun 21, 2018
Nav Experian redefines marketing to help automotive brands better engage and connect with car buyers | Jun 21, 2018
Nav Star Tribune names Loffler Companies a 2018 Top Workplace | Jun 21, 2018
Nav Xulon Press Releases Robert Smith's "The Believer's Mandate" | Jun 21, 2018
Nav Tom Edwards's Taut Thriller Receives 5-Star Review Calling it a "Gripping Epic" | Jun 21, 2018
Nav Tulip Recognized as Technology Pioneer by World Economic Forum for Helping Manufacturing Workers Stay Competitive | Jun 21, 2018
NEWS SEARCH

FEATURED NEWS | POPULAR NEWS
Submit News | View More News View More News